Anticancer efficacy of the irreversible EGFr tyrosine kinase inhibitor PD 0169414 against human tumor xenografts
Titel:
Anticancer efficacy of the irreversible EGFr tyrosine kinase inhibitor PD 0169414 against human tumor xenografts
Auteur:
Vincent, Patrick W. Bridges, Alex J. Dykes, Donald J. Fry, David W. Leopold, Wilber R. Patmore, Sandra J. Roberts, Billy J. Rose, Steven Sherwood, Veronika Zhou, Hairong Elliott, William L.